Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TRIADE: Amitifadine in MDD Inadequate Responders
NCT01318434Phase 3Completed
- Sponsor
- Ethismos Research
- Start
- Feb 2011
- Primary completion
- Feb 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of amitifadine in major depressive disorder (MDD), sponsored by Ethismos Research. Started Feb 2011; status: completed.
02
Drugs
amitifadine
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on NCT01318434.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01318434.